🔷 مدنیزاده: شیوه فعلی قیمتگذاری دارو پاسخگو نیست* ✅یکی از صریحترین مواضع یکصدوسیوهفتمین نشست دیروز شورای گفتوگوی دولت و بخش خصوصی، *انتقاد وزیر اقتصاد از مدل فعلی قیمتگذاری دارو* بود. ✅مدنیزاده با بیان اینکه روش موجود، حقوق تولیدکنندگان را به طور کامل تأمین نمیکند، گفت: وزارت بهداشت و سازمان غذا و دارو باید با مشارکت بخش خصوصی، *سازوکاری منطقیتر برای تعیین قیمت دارو طراحی کنند*؛ مدلی که ضمن حفظ توان تولیدک…

Channel
دتماد
@detmad
On this record: Growth · Engagement · Reactions · Posts · Citations · Cite this entry
153subscribers
+1 since we began measuring on 6 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
Register entry
| Telegram ID | -1001184256789 |
|---|---|
| Type | Channel |
| Username | @detmad |
| Created | Between 1 March 2018 and 31 July 2021 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 8 August 2026 |
| Last confirmed live | 5 September 2026 |
| Measurements held | 3 |
| Confirmed unchanged | 1 time, most recently 5 September 2026 |
| On Telegram | t.me/detmad |
Growth
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 5 Sept 2026, 11:55 | 153 | +1 |
| 8 Aug 2026, 19:17 | 152 | no change |
| 6 Aug 2026, 12:19 | 152 | first reading |
Engagement
17 posts held, back to 8 January 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 17 posts for this entry, the most recent from 30 July 2026. An engagement rate over an empty window would be a number about nothing.
Reaction mix
1 reaction across 1 post, in 1 kind.
| Reaction | Count | Share | Share, drawn |
|---|---|---|---|
| ❤ | 1 | 100.0% |
No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.
Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.
Coverage. Reactions were read on 2 of the 17 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 1 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.
Measured over the 17 most recent posts we hold, published 8 January 2026 to 30 July 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.
Recent posts
🔵 بررسی هلدینگهای دارویی 🔵 🔴 در این پست به بررسی ۵ هلدینگ دارویی فعال در بازار سرمایه پرداختیم. علاوه بر ارزیابی سود خالص و خالص ارزش داراییهای(NAV) هر شرکت، جزئیات پورتفو بورسی هر کدام نیز مورد ارزیابی قرار گرفت. 🌐انیگما
🔷گزارش های بهار ۱۴۰۵ شرکت های داروسازی 🌐بهین بورس
🔷گزارش های بهار ۱۴۰۵ شرکت های داروسازی 🌐بهین بورس
🔷بررسی وضعیت بنیادی صنعت دارو 🌐علی اسکینی
🔷تحلیل پیشرفته گزارش های حسابرسی صنعت دارو 🌐دکتر سیاوش افتخاری
رشد ۸۶ درصدی سود خالص تماد نسبت به سال ۱۴۰۳ 🔹مجمع عمومی عادی سالیانه صاحبان سهام شرکت تولید مواد اولیه داروپخش (تماد) وابسته به شستا برای سال مالی منتهی به ۲۹ اسفندماه ۱۴۰۴ با حضور ۷۷.۸۲ درصد از سهامداران برگزار شد. 🔹شرکت تماد رتبه اول فروش ریالی بین شرکتهای ماده اولیهساز بورسی با رشد ۴۲ درصدی نسبت به سال قبل، رتبه دوم بین کل شرکتهای دارویی بورسی با ۵.۴ میلیون دلار صادرات و رشد ۸۶ درصدی سود خالص نسبت به سال ۱…
رکوردشکنی پارس دارو و تماد در فروش خردادماه 🔹شرکتهای پارس دارو و تولید مواد اولیه داروپخش (تماد) وابسته به شستا توانستند همچنان ارقام تولید و فروش خود را در سال جاری ارتقا دهند. 🔹شرکت پارس دارو با عبور از فروش 8 هزار و 45 میلیارد ریالی در خرداد ماه امسال ضمن ثبت رکورد جدید و بی سابقهای در فروش ماهیانه، با رشد بیش از 4 برابری فروش نسبت به مدت مشابه سال، عملکرد خیره کنندهای داشته است. 🔹شرکت تولید مواد اولیه داروپ…
🔷 بازدهی یک ساله گروه داروئی
#دتماد 📉 مقايسه عملکرد نماد دتماد از گروه مواد و محصولات شیمیایی در میزان فروش و سود دهی در یکسال گذشته. 📊🍽 🌐 علی محمودیان
تحلیل عملکرد صادرات داروی ایران از ۱۴۰۰ تا ۱۴۰۴ 🔹 ارزش صادرات داروی ایران طی پنج سال اخیر به شرح زیر است 🔹۱۴۰۰: ۵۲/۴ میلیون دلار 🔹۱۴۰۱: ۶۹/۷ میلیون دلار 🔹۱۴۰۲: ۶۱/۳ میلیون دلار 🔹۱۴۰۳: ۸۹/۳ میلیون دلار 🔹۱۴۰۴: ۱۱۰/۷ میلیون دلار 🔹کل ۵ سال: ۳۸۳/۴ میلیون دلار 🔴مقاصد اصلی صادراتی: ۱- سوریه: ۵۵/۱ میلیون دلار ۲- عراق: ۴۱/۲ میلیون دلار ۳- روسیه: ۳۱ میلیون دلار ۴- افغانستان: ۲۵ میلیون دلار ۵- پاکستان: ۱۲/۹ میلیون دلار
تحلیل عملکرد صنعت دارویی (شرکتهای بورس اوراق بهادار - ۱۴۰۴) 🌐فانا
Showing the 12 most recent of 17 posts we hold for @detmad. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Forward network
Republished by
Channels on the register that have forwarded this channel's posts into their own feed.
Republishes
Channels on the register whose posts this channel has forwarded.
Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.
Mentions
Names
Channels on the register whose handles appear in this channel's posts.
A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.
Cite this entry
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 5 September 2026 — this entry's latest reading, not the date you are reading this.
“دتماد” (@detmad), 153 subscribers as measured 5 September 2026. Telegram Register, tgregister.com/channel/detmad.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.